Skip to content
AI IntelligenceMay 22, 2026Secondary Market
Article

TPST

Tempest Therapeutics, Inc. received a delisting notice from Nasdaq and has filed an 8-K disclosing the event. The company may seek to regain compliance.

Data Cube AI EditorialSource: SEC EDGAR
01

Source Brief

Tempest Therapeutics, Inc. received a delisting notice from Nasdaq and has filed an 8-K disclosing the event. The company may seek to regain compliance.